Edwards Lifesciences (EW) Change in Cash (2009 - 2026)

Edwards Lifesciences' Change in Cash history runs 18 years deep, the most recent figure standing at -$492.0 million for Q1 2026.

• In Q1 2026, Change in Cash fell 646.67% year-over-year to -$492.0 million; the TTM figure through Mar 2026 stood at -$701.3 million (down 136.53% YoY), while the FY2025 annual figure was -$119.3 million, down 106.24% from the prior year.
• Change in Cash was -$492.0 million for Q1 2026 at Edwards Lifesciences, down from $244.7 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $2.0 billion in Q3 2024 to a low of -$624.6 million in Q4 2024.
• Historically, Change in Cash has averaged $92.9 million across 5 years, with a median of $103.8 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Change in Cash surged 1905.38% in 2022, then sank 646.67% in 2026.
• A 5-year view of Change in Cash shows it stood at -$479.1 million in 2022, then soared by 44.5% to -$265.9 million in 2023, then sank by 134.9% to -$624.6 million in 2024, then soared by 139.18% to $244.7 million in 2025, then tumbled by 301.06% to -$492.0 million in 2026.
• The last three Change in Cash figures came in at -$492.0 million (Q1 2026), $244.7 million (Q4 2025), and -$595.2 million (Q3 2025), per Business Quant data.